Using Bayesian proof-of-concept criteria to design randomized phase II oncology trials stratified by biomarker status. K. V. Appanna, E. P. H. Zuber, V. Jehl, Y. Zhang, Y. Wang,A. racine-Poon,B. NeuenschwanderJournal of Clinical Oncology（2011）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
